BlackRock veteran Bob Doll predicts the US stock market could achieve annualised returns of 8% over the next decade.
The manager of the Finsbury Worldwide Pharmaceutical trust believes companies manufacturing generic medicines will continue to outperform the pharma giants.
Polar Capital has raised £89m for its new Global Healthcare Growth & Income trust.
Polar Capital's forthcoming Global Healthcare Growth & Income trust will launch with a partial allocation to growth stocks that overlaps existing holdings in its Healthcare Opportunities fund.
Asset.TV talks to manager Daniel Mahony about his Polar Capital Global Healthcare Growth & Income Trust
Polar Capital plans to launch a healthcare-focused investment trust targeting the historically low valuations on offer in the sector.
Aberdeen's Paul Atkinson is buying back into US healthcare stocks following the announcement of President Obama's insurance reforms.
The Biotech Growth trust is planning to raise up to £50m through a new share offering.